Browse Newsroom

Interview in Dagens Medicin with Åge Nærdal

August 3, 2022

InsuLife was featured in the August 3, 2022 article titled "Insulife vil folkefinansiere studie på insulinspray"

Read the Article

Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved